` Comparison: HPM vs BN - Alpha Spread

H
HPM
vs
BN

Over the past 12 months, HPM has underperformed BN, delivering a return of -60% compared to the BN's +1% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
HPM
BN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

H
HPM Intrinsic Value
13.73 PLN
Overvaluation 83%
Intrinsic Value
Price
BN Intrinsic Value
85.29 EUR
Undervaluation 16%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
H
Hipromine SA
WSE:HPM
82 PLN
Danone SA
PAR:BN
71.26 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
HPM, BN

Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
H
Hipromine SA
Revenue
Danone SA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
HPM, BN

Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
H
Hipromine SA
WSE:HPM
Danone SA
PAR:BN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

HPM
12.2%
BN
50.6%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Hipromine SA
Danone SA

Operating Margin

HPM
-417.2%
BN
13.4%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Hipromine SA
Danone SA

Net Margin

HPM
-508.1%
BN
6.7%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Hipromine SA
Danone SA

FCF Margin

HPM
-310.4%
BN
10%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Hipromine SA
Danone SA

ROE

HPM
-143%
BN
10.5%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Hipromine SA
Danone SA

ROA

HPM
-22.1%
BN
4%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Hipromine SA
Danone SA

ROIC

HPM
-18.9%
BN
7.7%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Hipromine SA
Danone SA

ROCE

HPM
-20.6%
BN
11.8%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Hipromine SA
Danone SA

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
HPM, BN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
HPM, BN

Loading
HPM
BN
Difference
www.alphaspread.com

Performance By Year
HPM, BN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare HPM to other stocks
2230
Goyo Foods Industry Co Ltd
G
More expensive
vs HPM
NESN
Nestle SA
Cheaper
vs HPM
MDLZ
Mondelez International Inc
Cheaper
vs HPM
TBS
Tiger Brands Ltd
T
Cheaper
vs HPM
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett